Keyphrases
Selenium Supplementation
100%
Graves' Hyperthyroidism
100%
Study within a Trial
100%
Grass
100%
Antithyroid Drugs
100%
Randomized Controlled Trial
100%
Selenium
77%
First Year
33%
Thyroid Gland
22%
Once-daily
22%
Quality of Life
22%
Adverse Reactions
22%
Placebo
22%
Treatment Failure
22%
Remission
22%
Exclusion Criteria
11%
Life Data
11%
Euthyroid
11%
Further Treatment
11%
Medical Charts
11%
Clinical Quality
11%
Adverse Events
11%
Management System
11%
National Database
11%
Quality of Life Improvement
11%
Patient-reported Outcomes
11%
Daily Clinical Practice
11%
Immunomodulatory Drugs (IMiDs)
11%
Informed Consent
11%
Beneficial Effects
11%
High-quality Data
11%
Radioactive Iodine Therapy
11%
Specific Quality of Life
11%
Hyperthyroid
11%
Trial Management
11%
Hospitalization
11%
Autoimmune Hypothyroidism
11%
Inclusion Criteria
11%
Investigator-initiated
11%
Pragmatic Trial
11%
Patient Feedback
11%
Clinical Course
11%
Selenoprotein
11%
Breast
11%
Treatment Efficacy
11%
Serious Adverse Events
11%
Allergy
11%
Cause of Disease
11%
Comorbidity
11%
Multicenter Clinical Trial
11%
Graves' Orbitopathy
11%
Thyrotropin Receptor Antibody (TRAb)
11%
Autoimmune Disease
11%
Treatment as Usual
11%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Graves Disease
100%
Antithyroid Agent
100%
Pharmacotherapy
55%
Adverse Event
44%
Placebo
22%
Tablet
22%
Remission
22%
Autoimmune Disease
11%
Thyrotropin Receptor
11%
Disease Course
11%
Receptor Antibody
11%
Hypothyroidism
11%
Clinical Trial
11%
Selenoprotein
11%
Comorbidity
11%
Radioactive Iodine
11%
Liotrix
11%